Identification of an Anti-MRSA Cyclic Lipodepsipeptide, WBP-29479A1, by Genome Mining of Lysobacter antibioticus

Org Lett. 2019 Aug 16;21(16):6432-6436. doi: 10.1021/acs.orglett.9b02333. Epub 2019 Aug 6.

Abstract

Lysobacter are ubiquitous in the environment but remain largely underexplored, although the bacteria are considered "peptide specialists". Here, we identified a new cyclic lipodepsipeptide, WBP-29479A1 (1), through genome mining of L. antibioticus ATCC 29479. 1 is biosynthesized by a large NRPS gene cluster, and its structure, including the six nonproteinogenic residues and 3-hydroxy fatty acid, was determined by extensive spectroscopic analyses and chemical derivatization. 1 exhibits potent anti-MRSA activity in a menaquinone-dependent manner.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / chemistry*
  • Anti-Bacterial Agents / metabolism
  • Anti-Bacterial Agents / pharmacology*
  • Depsipeptides / chemistry
  • Depsipeptides / pharmacology
  • Genome, Bacterial
  • Hemolytic Agents / chemistry
  • Hemolytic Agents / pharmacology
  • Humans
  • Lysobacter / genetics*
  • Lysobacter / metabolism
  • Methicillin-Resistant Staphylococcus aureus / drug effects
  • Microbial Sensitivity Tests
  • Molecular Structure
  • Multigene Family
  • Mutation
  • Peptide Synthases / genetics
  • Peptide Synthases / metabolism
  • Valine

Substances

  • Anti-Bacterial Agents
  • Depsipeptides
  • Hemolytic Agents
  • Peptide Synthases
  • non-ribosomal peptide synthase
  • Valine

Supplementary concepts

  • Lysobacter antibioticus